STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE DRUG PIPELINE ANALYSIS REPORT 2024

According to the Leukemia & Lymphoma Society, acute graft-versus-host disease (aGvHD) affects approximately 40-50% of patients receiving allogeneic stem cell transplantation. It occurs when the body's immune system (transplanted along with a donor organ or stem cells) attacks the recipient's tissues. Several clinical trials are ongoing to devel